NEW YORK (360Dx) – Progentec Diagnostics said today that it has raised $1.25 million in a second round of funding that will support development of its tool for identifying lupus flare ups and its biomarker-based disease-activity index.
The firm also said that it has acquired LupusCorner, a health management platform for people with systemic lupus erythematosus and lupus nephritis. Integrating LupusCorner’s technology platform and data insights positions Progentec to develop a "first-in-class lupus-management platform," the diagnostics firm said.